Cargando…

Hydroxychloroquine in the management of critically ill patients with COVID-19: the need for an evidence base

Detalles Bibliográficos
Autores principales:	Taccone, Fabio S, Gorham, Julie, Vincent, Jean-Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7159849/ https://www.ncbi.nlm.nih.gov/pubmed/32304640 http://dx.doi.org/10.1016/S2213-2600(20)30172-7

Ejemplares similares

Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
por: Gorham, Julie, et al.
Publicado: (2023)

Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review
por: Gorham, Julie, et al.
Publicado: (2022)

Interleukine-6 in critically ill COVID-19 patients: A retrospective analysis
por: Gorham, Julie, et al.
Publicado: (2020)

Hydroxychloroquine lung pharmacokinetics in critically ill patients with COVID-19
por: Ruiz, S., et al.
Publicado: (2021)

The value of blood lactate kinetics in critically ill patients: a systematic review
por: Vincent, Jean-Louis, et al.
Publicado: (2016)

Harmful Effects of Hyperoxia in Postcardiac Arrest, Sepsis, Traumatic Brain Injury, or Stroke: The Importance of Individualized Oxygen Therapy in Critically Ill Patients
por: Vincent, Jean-Louis, et al.
Publicado: (2017)

Hydroxychloroquine pharmacokinetic in COVID-19 critically ill patients: an observational cohort study
por: Painvin, Benoit, et al.
Publicado: (2020)

Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

Understanding pathways to death in patients with COVID-19
por: Vincent, Jean-Louis, et al.
Publicado: (2020)

Erratum to: Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19
por: Yu, Bo, et al.
Publicado: (2020)

Effects of fluid administration on renal perfusion in critically ill patients
por: Moussa, Mouhamed Djahoum, et al.
Publicado: (2015)

Advances in antibiotic therapy in the critically ill
por: Vincent, Jean-Louis, et al.
Publicado: (2016)

How to Use Nebulized Antibiotics in Severe Respiratory Infections
por: Gorham, Julie, et al.
Publicado: (2023)

Continuous infusion of meropenem in critically ill patients: practical considerations
por: Taccone, Fabio Silvio
Publicado: (2012)

Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence
por: Roustit, M., et al.
Publicado: (2020)

Incoherence between Systemic Hemodynamic and Microcirculatory Response to Fluid Challenge in Critically Ill Patients
por: De Santis, Paolo, et al.
Publicado: (2021)

Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
por: Arabi, Yaseen M., et al.
Publicado: (2021)

Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS
por: Ego, Amédée, et al.
Publicado: (2021)

Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence
por: Cohen, Myron S.
Publicado: (2020)

Evidence for Chloroquine/Hydroxychloroquine in the Treatment of COVID-19
por: Shetty, Rajesh M, et al.
Publicado: (2021)

From hydroxychloroquine to ivermectin: how unproven “cures” can go viral
por: Taccone, Fabio Silvio, et al.
Publicado: (2022)

Hydroxychloroquine: balancing the needs of LMICs during the COVID-19 pandemic
por: Banerjee, Soumya
Publicado: (2020)

Hydroxychloroquine for prophylaxis in COVID-19: Need to revisit dosing regimen
por: Pareek, Anil, et al.
Publicado: (2020)

Corticosteroids in severe COVID-19: a critical view of the evidence
por: De Backer, Daniel, et al.
Publicado: (2020)

A Retrospective, Monocentric Study Comparing Co and Secondary Infections in Critically Ill COVID-19 and Influenza Patients
por: Marcoux, Diane, et al.
Publicado: (2022)

High Quality Targeted Temperature Management (TTM) After Cardiac Arrest
por: Taccone, Fabio Silvio, et al.
Publicado: (2020)

Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology
por: Gleeson, Patrick James, et al.
Publicado: (2023)

A critical analysis and review of Lancet COVID-19 hydroxychloroquine study
por: Toumi, Mondher, et al.
Publicado: (2020)

Does hydroxychloroquine combat COVID-19? A timeline of evidence
por: Alia, Erisa, et al.
Publicado: (2020)

The Acquisition of Multidrug-Resistant Bacteria in Patients Admitted to COVID-19 Intensive Care Units: A Monocentric Retrospective Case Control Study
por: Bogossian, Elisa G., et al.
Publicado: (2020)

Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed()
por: Tahiri Joutei Hassani, Rachid, et al.
Publicado: (2020)

Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
por: Devaux, Christian A., et al.
Publicado: (2021)

Early management of critically ill patients with COVID‐19
por: Gutiérrez‐Zarate, Damián, et al.
Publicado: (2020)

Clinical review: Scoring systems in the critically ill
por: Vincent, Jean-Louis, et al.
Publicado: (2010)

Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID‐19 Epidemic
por: Romani, Serena, et al.
Publicado: (2020)

Hydroxychloroquine for early treatment of COVID-19: Absence of evidence is different from evidence of absence
por: Furlan, Leonardo
Publicado: (2022)

Chloroquine, hydroxychloroquine and COVID-19
por: Erickson, T. B., et al.
Publicado: (2020)

Hydroxychloroquine and COVID-19: The endgame!
por: Deplanque, Dominique
Publicado: (2023)

Difficulty interpreting the results of some trials: the case of therapeutic hypothermia after pediatric cardiac arrest
por: Vincent, Jean-Louis, et al.
Publicado: (2015)

Automated Pupillometry for Prediction of Electroencephalographic Reactivity in Critically Ill Patients: A Prospective Cohort Study
por: Peluso, Lorenzo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fq0j53ags3etsk7puunluk3to5